Isaac Chan, M.D., Ph.D.

Isaac Chan, M.D. Ph.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Hematology and Oncology. He specializes in immunotherapy, breast cancer, and metastatic cancer.

Dr. Chan earned both his doctoral degree in genetics and molecular signaling and his medical degree at the University of North Carolina at Chapel Hill.  He completed internal medicine residency training at Boston University and received advanced training through a medical oncology fellowship at the Johns Hopkins University School of Medicine in Baltimore.

Certified by the American Board of Internal Medicine, Dr. Chan joined the UT Southwestern faculty in 2020.

Dr. Chan’s research involves understanding how to treat and prevent metastatic disease by studying the processes by which cancer cells spread. He has delivered numerous invited talks and published countless academic articles on this subject. Additionally, he has written several op-ed pieces about patient-centered care, including for The Washington Post, and has also worked closely with patient advocates in breast cancer and the organization Guiding Researchers and Advocates to Scientific Partnerships (GRASP).

Dr. Chan is a member of the American Association for Cancer Research and the Society for Immunotherapy of Cancer.

In 2019, Dr. Chan earned the Conquer Cancer Young Investigator Award in Breast Cancer from the American Society of Clinical Oncology Foundation.

Personal Note

Outside of medicine, his interests include spending time with family and friends, cooking, and reading biographies and books on American history.

Other Post Graduate Training

University of North Carolina (2012)

Medical School

University of North Carolina at Chapel Hill School of Medicine (2014)

Residency

Boston University Medical Center (2016), Internal Medicine

Fellowship

Johns Hopkins University (2020), Medical Oncology

• Breast Cancer
• Cancer Metastasis
• Tumor Immunology
• Tumor Immunotherapy

Featured Publications

Cancer cells educate natural killer cells to a metastasis-promoting cell state.

Chan IS, Knútsdóttir H, Ramakrishnan G, Padmanaban V, Warrier M, Ramirez JC, Dunworth M, Zhang H, Jaffee EM, Bader JS, Ewald AJ, J Cell Biol 2020 Sep 219 9

Impact of the Current US Preventive Services Task Force Recommendations for Cervical Cancer Screening in Young Women 21 to 29 Years Old.

Morris CP, Chowsilpa S, Mustafa S, Chan I, Miller D, Maleki Z, Rodriguez EF, Am J Clin Pathol 2020 05 153 6 734-742

An Acquired Factor X Inhibitor: The Importance of Understanding Coagulation.

Chan IS, Ogunsile FJ, Am J Med 2017 Jul 130 7 e307-e308

Delayed Diagnosis of Disseminated Cryptococcosis with Associated Meningoencephalitis in an Immunocompetent Septuagenarian Host.

Chan IS, Chudasama R, Burrows AB, Am J Med 2017 Jan 130 1 e31-e32

Schistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni.

Pereira TA, Syn WK, Machado MV, Vidigal PV, Resende V, Voieta I, Xie G, Otoni A, Souza MM, Santos ET, Chan IS, Trindade GV, Choi SS, Witek RP, Pereira FE, Secor WE, Andrade ZA, Lambertucci JR, Diehl AM, Clin Sci (Lond) 2015 Nov 129 10 875-83

Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation.

Xie G, Choi SS, Syn WK, Michelotti GA, Swiderska M, Karaca G, Chan IS, Chen Y, Diehl AM, Gut 2013 Feb 62 2 299-309

Hedgehog controls hepatic stellate cell fate by regulating metabolism.

Chen Y, Choi SS, Michelotti GA, Chan IS, Swiderska-Syn M, Karaca GF, Xie G, Moylan CA, Garibaldi F, Premont R, Suliman HB, Piantadosi CA, Diehl AM, Gastroenterology 2012 Nov 143 5 1319-1329.e11

• American Association for Cancer Research (2018)
• Society for Immunotherapy of Cancer (2020)